The BC-TCGA dataset showed improved performance: BHLHE41 (0.8477), EPCAM (0.8271), ADH4 (0.9437), GSTM2 (0.8428), and GADD45G (0.7357) (Figure 5B). This evidence concerns the gene GSTM2 and breast cancer.